THE CHEMICAL AND BIOCHEMICAL CONSEQUENCES OF THE BINDING OF THE ANTITUMOR DRUG CISPLATIN AND OTHER PLATINUM GROUP METAL-COMPLEXES TO DNA

被引：133

作者：

UMAPATHY, P

机构：

来源：

COORDINATION CHEMISTRY REVIEWS | 1989年 / 95卷 / 02期

关键词：

D O I：

10.1016/0010-8545(89)80025-6

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

引用

页码：129 / 181

页数：53

共 253 条

[61] CHARACTERIZATION OF THE ADDUCTS PRODUCED IN DNA BY CIS-DIAMMINEDICHLOROPLATINUM(II) AND CIS-DICHLORO(ETHYLENEDIAMINE)PLATINUM(II) [J].

EASTMAN, A .

BIOCHEMISTRY, 1983, 22 (16) :3927-3933

[62] A POSSIBLE ID PROCESS IN THE REACTION OF 5'-GUANOSINEMONOPHOSPHORIC ACID AND CIS[PT(NH2PRI)2(OH2)2]2+, A REDUCED FORM OF CHIP OR IPROPLATIN, THE ANTICANCER DRUG [J].

EVANS, DJ ;

GREEN, M .

JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1987, (02) :124-125

[63] THE RATE OF REDUCTION OF CIS-[PTIV(NH2PRI)2CL2(OH)2], CIS-[PTIV(NH2PRI)2CL2(OH)2], TRANS-[PTIV(NH2PRI)2CL2(OH)2], CHIP, THE ANTICANCER DRUG BY ASCORBIC-ACID [J].

EVANS, DJ ;

GREEN, M .

INORGANICA CHIMICA ACTA, 1987, 130 (02) :183-184

[64] DICHLOROTETRAKIS(DIMETHYL SULPHOXIDE)RUTHENIUM(II) AND ITS USE AS A SOURCE MATERIAL FOR SOME NEW RUTHENIUM(II) COMPLEXES [J].

EVANS, IP ;

SPENCER, A ;

WILKINSO.G .

JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1973, (02) :204-209

[65] CRYSTAL AND MOLECULAR-STRUCTURE OF BIS(MU-(1-METHYLURACILATO-N3,O4))-BIS(CIS-DIAMMINEPLATINUM(II)) DINITRATE TRIHYDRATE, [(NH3)2PT(C5H5N2O2)2PT(NH3)2](NO3)2.3H2O [J].

FAGGIANI, R ;

LOCK, CJL ;

POLLOCK, RJ ;

ROSENBERG, B ;

TURNER, G .

INORGANIC CHEMISTRY, 1981, 20 (03) :804-807

[66] DETECTION AND QUANTIFICATION OF ADDUCTS FORMED UPON INTERACTION OF DIAMMINEDICHLOROPLATINUM (II) WITH DNA, BY ANION-EXCHANGE CHROMATOGRAPHY AFTER ENZYMATIC DEGRADATION [J].

FICHTINGERSCHEPMAN, AMJ ;

LOHMAN, PHM ;

REEDIJK, J .

NUCLEIC ACIDS RESEARCH, 1982, 10 (17) :5345-5356

[67] INTERACTION OF CIS-DIAMMINEDICHLOROPLATINUM(II) TO CHROMATIN - SPECIFICITY OF THE DRUG DISTRIBUTION [J].

FOKA, M ;

PAOLETTI, J .

BIOCHEMICAL PHARMACOLOGY, 1986, 35 (19) :3283-3291

[68] P-31 NMR INVESTIGATION OF 14 SELF-COMPLEMENTARY OLIGODEOXYRIBONUCLEOTIDES (8-MER TO 14-MER) TREATED WITH PLATINUM COMPLEXES - THE DOWNFIELD P-31 NMR SIGNAL CHARACTERISTIC OF ANTICANCER DRUGS IS OBSERVED ONLY FOR MOLECULES WITH ADJACENT G RESIDUES [J].

FOUTS, CS ;

REILY, MD ;

MARZILLI, LG .

INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1987, 137 (1-2) :1-13

[69] HMQC AND H-1 AND P-31 NMR-STUDIES OF PLATINUM AMINE ADDUCTS OF TETRADEOXYRIBONUCLEOTIDES - RELATIONSHIP BETWEEN P-31 SHIFT AND POTENTIAL HYDROGEN-BONDING INTERACTIONS IN PGPG MOIETIES CROSS-LINKED BY PLATINUM [J].

FOUTS, CS ;

MARZILLI, LG ;

BYRD, RA ;

SUMMERS, MF ;

ZON, G ;

SHINOZUKA, K .

INORGANIC CHEMISTRY, 1988, 27 (02) :366-376

[70]

FOUTS CS, 1985, INORG CHIM ACTA, V106, P187

← 2 3 4 5 6 7 8 9 10 11 →